Babcock International Group PLC 25 Annual report and accounts 2006 Directors report The Directors present their Report and the audited Financial Statements of the group and company for the year ended 31 March 2006.
Result and dividends The profit attributable to shareholders for the financial year was 29.7 million 2005: 19.1 million.
An interim dividend of 1.75p per 60p ordinary share was declared in the year 2005: 1.35p per 60p ordinary share.
The Directors propose to recommend the payment on 7 August 2006 of a final dividend of 4.25p 2005: 2.65p per 60p ordinary share on each of the ordinary shares of 60p entitled thereto and in issue on 7 July 2005. Business review and group structure The Business review on pages 4 to 23 reviews the groups activities and likely future developments and forms part of this report.
That review also addresses use of financial instruments and describes important events since 31 March 2006.
The principal subsidiary and associated undertakings of the company are set out on page 84.
Acquisitions and disposals Information regarding the groups acquisitions and disposals during the course of the year are set out in note31 on page71 and are also referred to in the Business review.
Research and development The group commits resources to research and development where necessary for the evolution and growth of its business.
Charitable and political donations During the year the group donated 54,587 2005: 51,658 to charitable organisations.
No donations were made during the year for political purposes.
Supplier payments The group has a policy of making payments consistent with established practices agreed with suppliers.
There is no universal code or standard on payment practices across the countries in which the group does business, but subsidiary companies are expected to establish terms of trade consistent with the above policy and with the markets in which they operate, to ensure that suppliers are made aware of the terms of payment and to abide by them.
The company itself had no trade creditors at either 31 March 2006 or 31 March 2005.
Directors Details of the present Directors are shown on page 24.
Sir Nigel Essenhigh will retire at the companys forthcoming Annual General Meeting in July 2006 under the provisions of Article 92 of the companys Articles of Association, having last been reappointed as a Director at the companys Annual General Meeting in 2003.
Being eligible, he will offer himself for reappointment.
Lord Hesketh, having first been appointed as a Director in 1993, in accordance with the Combined Code submits himself for reappointment on an annual basis and will therefore retire at the Annual General Meeting and, being eligible, will offer himself for reappointment.
Mr Crookenden having been appointed by the Board with effect from 1 December 2005 will, in accordance with Article 97 of the Companys Articles of Association, retire and offer himself for reappointment at the Annual General Meeting.
Directors interests There is no contract or arrangement with the company or any of its subsidiaries subsisting at the date of this document in which any Director of the company is materially interested and which is significant in relation to the business of the company and its subsidiaries taken as a whole.
Mr Mike Turner who retired as a Director of the company on 31 December 2005 is, and until 4 May 2005 Lord Hesketh was, a Director of BAE Systems plc and details of the companys transactions with that company or its subsidiaries in the year are disclosed in note 35 on page 72.
The interests of the Directors in the issued share capital of the company, including family interests, all of which were beneficial, were, at the dates shown, as follows: At 31 March At 1 April Director 2006 2005 G A Campbell 49,685 49,685 P L Rogers 100,000 100,000 The Rt Hon Lord Hesketh KBE 8,249 8,249 W Tame 26,189 21,189 D J Shah 8,333 8,333 M J Turner CBE retired 31 December 2005 16,666 Sir Nigel Essenhigh GCB J L Rennocks J N A Crookenden appointed 1 December 2005 Holdings are all of ordinary shares of 60p each.
Reported at the time as 17,113, the number inadvertently omitted shares acquired through the Companys AESOP scheme described on page 26.
A correction was published through a Regulatory News Service on 24 June 2005.
Mr Turner disposed of his entire share holding on 16 December 2005, at a price of 226p per share.
He retired from the Board on 31 December 2005.
There were no changes in the Directors interests in shares between 31 March 2006 and 22 May 2006.
Details of options and awards over shares in the company granted to Directors up to 22 May 2006 and any exercise of them during the year are given on page 37.
Each Director holding share options or share awards is also deemed to be interested, for the purposes of sections 324 to 328 of the Companies Act 1985, in the shares held by the Babcock Employees Share Trust, being potential beneficiaries of that trust.
Babcock International Group PLC 26 Annual report and accounts 2006 Directors report continued Significant shareholdings As at 22 May 2006, the company had been notified in accordance with sections 198 to 208 of the Companies Act 1985 of the following major interests in its ordinary shares which represent interests in 3% or more of its issued ordinary share capital.
Number of Name 60p ordinary shares % Schroders Investment Management Limited 44,334,883 21.20 Fidelity International 8,096,205 3.87 Capital Group Companies 7,924,431 3.80 Barclays PLC 6,344,236 3.03 Deutsche Bank 6,312,840 3.02 Employee share schemes In addition to the 1999 executive share option schemes and 2003 Babcock Long-Term Incentive Plan which are described in more detail in the Remuneration Report, the company has the following employee share schemes: i All Employee Share Ownership Plan This plan is open to all UK employees including executive Directors who meet common service criteria.
It allows employees to purchase partnership shares in the company in the market out of pre-tax income, and could also be used by the company to award free and or matching shares to participants.
A tax-approved employee trust holds shares on behalf of participants.
The shares must generally be kept in trust for at least three years to obtain any tax advantages, and for five years to obtain maximum tax advantages.
To date the company has not made an offer of free or matching shares.
ii Babcock International Group PLC Sharesave Scheme This scheme was introduced in December 1997.
It enables share options to be granted linked to save-as-you-earn contracts.
Offers to participate must be made to all UK employees including executive Directors.
There are currently no outstanding options under the scheme.
Options could be granted at a discount of up to 20% off the market price of the shares at the time of the offer.
iii The Babcock International Group PLC Approved and Unapproved Executive Share Option Schemes Grants under these schemes were not performance-linked.
They are no longer operated.
Options granted under them, however, continue to subsist, but no current Directors hold any such options.
The Babcock 1999 Approved Executive Share Option Scheme and the Babcock 1999 Unapproved Executive Share Option Scheme the 1999 Schemes, which replaced these schemes, do provide for option grants to be linked to company performance, and are described in more detail in the Remuneration Report.
Employees Further information concerning the companys approach to employee matters including public interest disclosure and ethical standards, and its policy on disabled employees and employee involvement is included in the companys Corporate and Social Responsibility Review appearing on pages 27 and 28.
Authority to purchase own shares At the companys Annual General Meeting in July 2005, the shareholders authorised the company to make market purchases of up to 20.8 million of its own ordinary shares of 60p each.
That authority will expire at the forthcoming Annual General Meeting in July 2006.
Although no ordinary shares have been purchased by the company during the period from 19 July 2005 the date of the last Annual General Meeting to the date of this report, a resolution will be put to shareholders at the forthcoming Annual General Meeting to renew the authority to make market purchases of the companys ordinary shares up to a maximum of just under 10% of the companys issued share capital.
Disclosure of relevant audit information So far as the directors who are in office at the time of the approval of this report are aware, there is no relevant audit information namely, information needed by the companys auditors in connection with the preparation of their auditors report of which the auditors are unaware and each such Director has taken all reasonable steps to make himself aware of any relevant audit information and to establish that the auditors are aware of that information.
Qualifying third party indemnity provisions Under their respective Articles of Association, the Directors of the company are, and were during the year to 31 March 2006, entitled to be indemnified by the company and those UK subsidiaries of which they are or were Directors against liabilities and costs incurred in connection with the execution of their duties or the exercise of their powers, to the extent permitted by the Companies Act 1985.
Annual General Meeting This years Annual General Meeting will be held at The Royal Society of Medicine, 1 Wimpole Street, London W1G OAE on Friday, 14 July 2006, at 11.30 am.
The notice of meeting is on page 85 and a note on the resolution to be proposed at it as special business is set out on page 86.
Auditors  LLP are willing to continue in office as Auditors, and a resolution to reappoint them will be proposed at the forthcoming Annual General Meeting.
Approval of report Approved by the Directors on 22 May 2006 By Order of the Board A N Dungate Company Secretary 22 May 2006
